Partnership Opportunities

RRHEI continually seeks to build its pipeline by in-licensing approved or late stage products. RHEI focuses on specific therapeutic areas such as oncology, women’s health, infectious diseases, dermatology. Its Chinese operations manage the regulatory process, clinical development and sale of branded pharmaceuticals.

For additional information, please contact:

Joan Chypyha
RHEI Pharmaceuticals
Head of Corporate Development
Office: +1 289 234 2586
Cell: +1 289 221 3120
Fax: +1 289 234 2587